Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1093 | 1093 | 1150 | 1334 | 1721 | 3040 |
Fund Return | 9.35% | 9.35% | 14.95% | 10.08% | 11.47% | 11.76% |
Place in category | 217 | 217 | 84 | 100 | 32 | 80 |
% in Category | 21 | 21 | 8 | 23 | 8 | 26 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 856.75M | 5.85 | 7.83 | 19.37 | ||
AXA Framlington Global Technology F | 154.91M | 5.85 | 7.83 | 19.36 | ||
GB00B5LXGG05 | 714.32M | 9.93 | 12.94 | 16.96 | ||
AXA Framlington UK Mid Cap Fund S A | 3.45M | -1.31 | -3.04 | 4.43 | ||
AXA Framlington UK Mid Cap Fund S I | 8.12M | -1.30 | -3.05 | 4.46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.95B | 7.74 | 9.50 | 13.38 | ||
Wellington Global Health Care EquiG | 2.51B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 116.19M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.52B | 10.64 | 6.33 | 14.31 | ||
Pharmaceuticals Index Trust F Acc | 259.24K | 8.14 | 10.01 | 11.74 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.05 | 777.71 | +1.44% | |
UnitedHealth | US91324P1021 | 7.27 | 501.15 | +1.37% | |
Novo Nordisk B | DK0062498333 | 7.11 | 894.1 | +1.30% | |
Merck&Co | US58933Y1055 | 5.69 | 130.37 | +2.19% | |
Thermo Fisher Scientific | US8835561023 | 4.51 | 572.95 | -0.10% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review